Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence

Thumbnail
View/ Open

Show full item record

Author
Cummings, Doyle M.
URI
http://hdl.handle.net/10342/9739
Subject
 diabetes medication; self-efficacy scale; reported problems and adherence 
Date
2016-06-07
Citation:
APA:
Cummings, Doyle M.. (June 2016). Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence. Patient Preference and Adherence, (1003–1010. Retrieved from http://hdl.handle.net/10342/9739

Display/Hide MLA, Chicago and APA citation formats.

MLA:
Cummings, Doyle M.. "Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence". Patient Preference and Adherence. . (1003–1010.), June 2016. December 07, 2022. http://hdl.handle.net/10342/9739.
Chicago:
Cummings, Doyle M., "Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence," Patient Preference and Adherence 10, no. (June 2016), http://hdl.handle.net/10342/9739 (accessed December 07, 2022).
AMA:
Cummings, Doyle M.. Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence. Patient Preference and Adherence. June 2016; 10() 1003–1010. http://hdl.handle.net/10342/9739. Accessed December 07, 2022.
Collections